ARTICLE | Company News
Management tracks
March 24, 2015 1:54 AM UTC
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) appointed Timothy Wright as EVP of business development, strategy and innovation, effective April 13. Wright was director of the Drug Discovery and Development Institute at The Ohio State University Comprehensive Cancer Center.
Analgesic developer AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) appointed Howard Rosen interim CEO, effective April 1. Rosen succeeds Richard King, who is resigning as part of a restructuring that includes staff cuts of 36%. Rosen has been a director at AcelRx since 2008. ...